Phio Pharmaceuticals (PHIO) Capital Expenditures (2011 - 2025)
Phio Pharmaceuticals' (PHIO) quarterly Capital Expenditures came in at $7000.0 in Q3 2025, up 133.33% on a QoQ basis from $3000.0 in Q2 2025.
Phio Pharmaceuticals (PHIO) Capital Expenditures (2011 - 2025) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 15 years of Capital Expenditures data on file, last reported at $7000.0 in Q3 2025.
- Quarterly Capital Expenditures changed N/A year-over-year to $7000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $10000.0 (up 233.33% YoY) and the FY2025 annual result came in at $12000.0, up 1100.0% from the prior year.
- Capital Expenditures climbed to $7000.0 in Q3 2025, from $3000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $104000.0 in Q1 2022 to a low of $1000.0 in Q4 2024.
- A 5-year average of $17272.7 and a median of $7000.0 in 2022 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 1633.33% in 2022, down 76.67% in 2022.
- Tracing PHIO's Capital Expenditures over 5 years: stood at $30000.0 in 2021, then plunged by 76.67% to $7000.0 in 2022, then retreated by 28.57% to $5000.0 in 2023, then tumbled by 80.0% to $1000.0 in 2024, then surged by 600.0% to $7000.0 in 2025.
- The last three Capital Expenditures figures came in at $7000.0 (Q3 2025), $3000.0 (Q2 2025), and $2000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 34.68 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.26 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 251.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -73.57 Mn |
| 10 | Phio Pharmaceuticals | 14.06 Mn | 14.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7,000.00 |
| Sep 30, 2025 | 7,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | 104,000.00 |
| Mar 31, 2022 | 104,000.00 |
| Sep 30, 2021 | 30,000.00 |
| Sep 30, 2021 | 30,000.00 |
| Jun 30, 2021 | 15,000.00 |
| Jun 30, 2021 | 15,000.00 |